Effects of endocervical administration of prostaglandin E2 on cervical dilatation and connective tissue biosynthesis in the first trimester of pregnancy.
D002584:Cervix Uteri / Q000187:drug effects*; D004107:Dilatation and Curettage; D015232:Dinoprostone; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011458:Prostaglandins E / Q000009:adverse effects / Q000627:therapeutic use*; D014619:Vacuum Curettage
D011458:Prostaglandins E; D015232:Dinoprostone